Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
228.00
78.00
-408.00
-682.00
-657.00
-535.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-51.00
-143.00
-10.00
111.00
-12.00
-32.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
384.00
209.00
-92.00
-357.00
-440.00
-253.00
Cash Flow from Investing Activities
-200.00
-148.00
-110.00
-178.00
-101.00
-211.00
Cash Flow from Financing Activities
1,081.00
-78.00
-31.00
705.00
264.00
975.00
Net Cash Inflow / Outflow
1,268.00
-14.00
-230.00
186.00
-278.00
506.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
2.00
3.00
16.00
0.00
-4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
228.114307704314
600.419251116314
-372.00
-62.01%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-51.1547983502448
87.8485620752741
-138.00
-158.23%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
384.671763408349
787.426869500128
-403.00
-51.15%
Cash Flow from Investing Activities
-200.482821265043
-935.122684741989
735.00
78.56%
Cash Flow from Financing Activities
1081.34788629315
-196.532987148871
1,277.00
650.21%
Net Cash Inflow / Outflow
1268.62121290279
-344.474989195886
1,612.00
468.28%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.08438446633515
-0.246186805154036
3.00
1352.86%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 83.74% vs 325.70% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
384.67
209.36
83.74%






